Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Study of Immunomodulator (Mycobacterium w) as an Adjunct Therapy in Category-II Pulmonary Tuberculosis Along With Assessment of Immunological Parameters

NCT00265226 is registered in ClinicalTrials.gov with Ministry of Science and Technology, India as lead sponsor.

NCT NCT00265226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00265226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Study of Immunomodulator (Mycobacterium w) as an Adjunct Therapy in Category-II Pulmonary Tuberculosis Along With Assessment of Immunological Parameters
Lead sponsor
Ministry of Science and Technology, India
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2005
Completion date
March 31, 2011
Enrollment
1,020 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis